Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01430403
Show Display Options
Rank Status Study
1 Completed
Has Results
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Condition: Asthma
Interventions: Biological: Omalizumab+Conventional Therapy;   Drug: Fluticasone+Conventional Therapy;   Biological: Placebo omalizumab+Conventional Therapy;   Biological: Placebo fluticasone+Conventional Therapy

Study has passed its completion date and status has not been verified in more than two years.